PL3621596T3 - Tabletki z wektorami kwasów nukleinowych - Google Patents

Tabletki z wektorami kwasów nukleinowych

Info

Publication number
PL3621596T3
PL3621596T3 PL18738197.5T PL18738197T PL3621596T3 PL 3621596 T3 PL3621596 T3 PL 3621596T3 PL 18738197 T PL18738197 T PL 18738197T PL 3621596 T3 PL3621596 T3 PL 3621596T3
Authority
PL
Poland
Prior art keywords
tablets
nucleic acid
acid vectors
vectors
nucleic
Prior art date
Application number
PL18738197.5T
Other languages
English (en)
Inventor
Virginie BUSIGNIES-GODDIN
Pascal Bigey
Christine Charrueau
Virginie Escriou
Pierre Tchoreloff
Original Assignee
Université De Bordeaux
Centre National De La Recherche Scientifique
Institut Polytechnique De Bordeaux
Ecole Nationale Supérieure D'arts Et Métiers
Université Paris Cité
Paris Sciences Et Lettres
Institut National de la Santé et de la Recherche Médicale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59974512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3621596(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Université De Bordeaux, Centre National De La Recherche Scientifique, Institut Polytechnique De Bordeaux, Ecole Nationale Supérieure D'arts Et Métiers, Université Paris Cité, Paris Sciences Et Lettres, Institut National de la Santé et de la Recherche Médicale filed Critical Université De Bordeaux
Publication of PL3621596T3 publication Critical patent/PL3621596T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18738197.5T 2017-05-10 2018-05-09 Tabletki z wektorami kwasów nukleinowych PL3621596T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1754105A FR3066115B1 (fr) 2017-05-10 2017-05-10 Comprimes de vecteurs d'acides nucleiques
PCT/EP2018/062141 WO2018206723A1 (fr) 2017-05-10 2018-05-09 Comprimes de vecteurs d'acides nucleiques

Publications (1)

Publication Number Publication Date
PL3621596T3 true PL3621596T3 (pl) 2022-10-24

Family

ID=59974512

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18738197.5T PL3621596T3 (pl) 2017-05-10 2018-05-09 Tabletki z wektorami kwasów nukleinowych

Country Status (8)

Country Link
US (2) US12115257B2 (pl)
EP (1) EP3621596B1 (pl)
JP (4) JP7752941B2 (pl)
DK (1) DK3621596T3 (pl)
ES (1) ES2913778T3 (pl)
FR (1) FR3066115B1 (pl)
PL (1) PL3621596T3 (pl)
WO (1) WO2018206723A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3066115B1 (fr) 2017-05-10 2019-06-28 Universite de Bordeaux Comprimes de vecteurs d'acides nucleiques
CN112390261A (zh) * 2019-08-13 2021-02-23 斯特里特技术有限公司 气相二氧化硅颗粒分离脱氢的系统和方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2564525A (en) * 1946-07-15 1951-08-14 Locke Stove Company Cook stove
US2724173A (en) * 1950-06-12 1955-11-22 Girard Alexandre Auguste Leon Method of manufacturing pressure chambers
JPH0278623A (ja) 1988-09-14 1990-03-19 Sawai Seiyaku Kk インターフェロン誘起剤
JPH11335269A (ja) * 1998-05-19 1999-12-07 Hisamitsu Pharmaceut Co Inc 遺伝子関連医薬の経口投与固形製剤
BR9911071A (pt) 1998-05-27 2001-02-06 Euro Celtique Sa Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
DE60142899D1 (de) * 2000-06-20 2010-10-07 Dainippon Sumitomo Pharma Co Verbindungen für den transfer von oligonukleotiden
US20030124196A1 (en) * 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
US20060099243A1 (en) 2002-05-20 2006-05-11 Oradel Medical Ltd. Liposome drug delivery
WO2005026186A1 (de) * 2003-09-12 2005-03-24 Max-Delbrück-Centrum für Molekulare Medizin Β-l-nucleoside und ihre verwendung als pharmazeutische mittel zur behandlung viraler erkrankungen
WO2005105838A2 (en) * 2004-04-28 2005-11-10 Paradigm Therapeutics Limited Ion channel
EP1920765A1 (en) * 2006-11-07 2008-05-14 Medigene AG Liposome preparation by single-pass process
EP2099496A2 (en) * 2006-12-08 2009-09-16 Massachusetts Institute of Technology Delivery of nanoparticles and/or agents to cells
US20110110861A1 (en) * 2008-05-13 2011-05-12 Mireille Hanna Lahoud Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
US20110027293A1 (en) * 2008-12-22 2011-02-03 Ali Munawar Methods and compositions for the inhibition of viral infection by targeting intracellular trafficking
US8765706B2 (en) * 2009-09-02 2014-07-01 Kyoto Prefectural Public University Corporation Composition comprising rna derived from lactic acid bacterium as effective component
PT2817287T (pt) * 2012-02-24 2018-12-28 Arbutus Biopharma Corp Lípidos catiónicos trialquílicos e seus métodos de utilização
US10501512B2 (en) * 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
CN105026411A (zh) * 2013-03-14 2015-11-04 夏尔人类遗传性治疗公司 含4’-硫代修饰的核苷酸的核糖核酸及相关方法
US10246560B2 (en) 2013-08-13 2019-04-02 Baylor College Of Medicine PLGA-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug delivery
EP3041938A1 (en) * 2013-09-03 2016-07-13 Moderna Therapeutics, Inc. Circular polynucleotides
US20150127582A1 (en) * 2013-11-04 2015-05-07 Pantheon Ventures (UK) LLP System, method, and computer readable medium for calculating mixed frequency valuation changes of illiquid assets
KR20160121584A (ko) * 2014-02-26 2016-10-19 에트리스 게엠베하 Rna의 위장 투여용 조성물
FR3066115B1 (fr) 2017-05-10 2019-06-28 Universite de Bordeaux Comprimes de vecteurs d'acides nucleiques

Also Published As

Publication number Publication date
DK3621596T3 (da) 2022-05-23
US20200163879A1 (en) 2020-05-28
US12115257B2 (en) 2024-10-15
JP2020519691A (ja) 2020-07-02
EP3621596A1 (fr) 2020-03-18
FR3066115A1 (fr) 2018-11-16
JP2023014439A (ja) 2023-01-30
FR3066115B1 (fr) 2019-06-28
JP2025013631A (ja) 2025-01-24
EP3621596B1 (fr) 2022-02-23
JP7752941B2 (ja) 2025-10-14
JP2024074832A (ja) 2024-05-31
ES2913778T3 (es) 2022-06-06
WO2018206723A1 (fr) 2018-11-15
US20250170063A1 (en) 2025-05-29

Similar Documents

Publication Publication Date Title
IL278000B (en) Synthetic nucleic acid transcripts
ZA201905396B (en) Trans-replicating rna
IL271239A (en) A method for developing nucleic acids
IL254000A0 (en) Nucleic acid sequence composition
GB201507119D0 (en) Nucleic Acid Construct
GB201507115D0 (en) Nucleic Acid Construct
GB201507111D0 (en) Nucleic acid construct
GB201507104D0 (en) Nucleic acid construct
GB201509578D0 (en) Vectors
GB201507108D0 (en) Nucleic acid construct
GB2558492B (en) Array antenna
GB201408841D0 (en) Nucleic acid processing
SG10201600867XA (en) Nucleic acid extracting device
LT3645717T (lt) Moduliniai nukleorūgščių adapteriai
ZA201905379B (en) 1-amino-1-cyclopropanecaboxylic acid formulations
GB201805223D0 (en) Nucleic acid amplification
SG11201803509XA (en) Magnetic-anchored robotic system
GB201509881D0 (en) Complementary vectors
GB201812474D0 (en) Nucleic acid construct
IL257500A (en) Altered cullin1 gene
PL3621596T3 (pl) Tabletki z wektorami kwasów nukleinowych
GB201513300D0 (en) Antenna Array
IL271510A (en) Determining the ratio between nucleic acids
GB2545291B (en) Robotic system
GB201608944D0 (en) Gene Tharapy